Literature DB >> 7711692

Quality of life bibliography and indexes: 1993 update.

R A Berzon1, G P Simeon, R L Simpson, M A Donnelly, H H Tilson.   

Abstract

Mesh：

Year:  1995        PMID： 7711692     DOI： 10.1007/bf00434384

Source DB:  PubMed          Journal:  Qual Life Res        ISSN： 0962-9343            Impact factor:   4.147


× No keyword cloud information.
  162 in total

1.  Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy.

Authors:  C B Dodrill; J L Arnett; K W Sommerville; N M Sussman
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

Review 2.  Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life.

Authors:  D A Revicki; R M Kaplan
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

Review 3.  Psychometric considerations in evaluating health-related quality of life measures.

Authors:  R D Hays; R Anderson; D Revicki
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

4.  Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group.

Authors:  T S Rector; G Johnson; W B Dunkman; G Daniels; L Farrell; A Henrick; B Smith; J N Cohn
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

Review 5.  Relevance of quality of life assessment to the evaluation of combined-modality therapy.

Authors:  C L Shapiro
Journal:  Semin Surg Oncol       Date:  1993 Jan-Feb

6.  Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients.

Authors:  L M Eri; K J Tveter
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

Review 7.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

Review 8.  Clinical uses of the quality-of-life in epilepsy inventory.

Authors:  O Devinsky
Journal:  Epilepsia       Date:  1993       Impact factor: 5.864

9.  Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors.

Authors:  J Douchez; J P Droz; B Desclaux; Y Allain; P Fargeot; A Caty; P Charrot
Journal:  J Urol       Date:  1993-03       Impact factor: 7.450

10.  Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency. Grupo para la Adaptación del HAQ a la Población Española.

Authors:  J Esteve-Vives; E Batlle-Gualda; A Reig
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666
View more
  5 in total

Review 1.  Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval.

Authors:  G Apolone; G De Carli; M Brunetti; S Garattini
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Searching for information on outcomes: do you need to be comprehensive?

Authors:  A J Brettle; A F Long; M J Grant; J Greenhalgh
Journal:  Qual Health Care       Date:  1998-09

3.  Discriminant and convergent validity of a subjective quality-of-life instrument aimed at high content validity for schizophrenic persons.

Authors:  M Franz; M Fritz; T Meyer
Journal:  Qual Life Res       Date:  2012-06-22       Impact factor: 4.147

4.  On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis.

Authors:  M M Murawski; P A Miederhoff
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

5.  Evidence for the sensitivity of the SF-36 health status measure to inequalities in health: results from the Oxford healthy lifestyles survey.

Authors:  C Jenkinson; R Layte; A Coulter; L Wright
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.